speb/financial-data huggingface dataset:
IVZ cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 155900000.00
IVZ cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 36000000.00
IVZ income_statement (annual, 2025-12-31) — Depreciation And Amortization In Income Statement: 1832400000.00
IVZ income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 1803600000.00
IVZ income_statement (annual, 2025-12-31) — Diluted Average Shares: 455000000.00
IVZ income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 453800000.00
IVZ income_statement (annual, 2025-12-31) — Diluted EPS: -1.60
IVZ income_statement (quarterly, 2025-12-31) — Diluted EPS: -2.63
IVZ income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -726300000.00
IVZ income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -1186200000.00
IVZ cash_flow (annual, 2025-12-31) — Dividend Received Cfo: 46800000.00
IVZ cash_flow (quarterly, 2025-12-31) — Dividend Received Cfo: 6100000.00
IVZ cash_flow (annual, 2025-12-31) — Dividends Received Cfi: 63100000.00
IVZ cash_flow (quarterly, 2025-12-31) — Dividends Received Cfi: 3400000.00
IVZ income_statement (annual, 2025-12-31) — EBIT: -296900000.00
IVZ income_statement (quarterly, 2025-12-31) — EBIT: -1322400000.00
IVZ income_statement (annual, 2025-12-31) — EBITDA: 1535500000.00
IVZ income_statement (quarterly, 2025-12-31) — EBITDA: 481200000.00
IVZ income_statement (annual, 2025-12-31) — Earnings From Equity Interest: 104800000.00
IVZ income_statement (quarterly, 2025-12-31) — Earnings From Equity Interest: 25400000.00
IVZ cash_flow (annual, 2025-12-31) — Earnings Losses From Equity Investments: -104800000.00
IVZ cash_flow (quarterly, 2025-12-31) — Earnings Losses From Equity Investments: -25400000.00
IVZ cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 82400000.00
IVZ cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: -3700000.00
IVZ balance_sheet (annual, 2025-12-31) — Employee Benefits: 1091200000.00
IVZ balance_sheet (quarterly, 2025-12-31) — Employee Benefits: 1091200000.00
IVZ cash_flow (annual, 2025-12-31) — End Cash Position: 1979800000.00
IVZ cash_flow (quarterly, 2025-12-31) — End Cash Position: 1979800000.00
IVZ cash_flow (annual, 2025-12-31) — Financing Cash Flow: -149500000.00
IVZ cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 356100000.00
IVZ cash_flow (annual, 2025-12-31) — Free Cash Flow: 1441000000.00
IVZ cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 432200000.00
IVZ cash_flow (annual, 2025-12-31) — Gain Loss On Investment Securities: -67900000.00
IVZ cash_flow (quarterly, 2025-12-31) — Gain Loss On Investment Securities: -40200000.00
IVZ balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -722900000.00
IVZ balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -722900000.00
IVZ income_statement (annual, 2025-12-31) — General And Administrative Expense: 576500000.00
IVZ income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 148700000.00
IVZ balance_sheet (annual, 2025-12-31) — Goodwill: 8477100000.00
IVZ balance_sheet (quarterly, 2025-12-31) — Goodwill: 8477100000.00
IVZ balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 12404400000.00
IVZ balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 12404400000.00
IVZ balance_sheet (annual, 2025-12-31) — Gross PPE: 1288900000.00
IVZ balance_sheet (quarterly, 2025-12-31) — Gross PPE: 1288900000.00
IVZ income_statement (annual, 2025-12-31) — Gross Profit: 2247200000.00
IVZ income_statement (quarterly, 2025-12-31) — Gross Profit: 626700000.00
IVZ balance_sheet (annual, 2025-12-31) — Held To Maturity Securities: 674200000.00
IVZ balance_sheet (quarterly, 2025-12-31) — Held To Maturity Securities: 674200000.00
IVZ cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 238700000.00
IVZ balance_sheet (annual, 2025-12-31) — Income Tax Payable: 100100000.00
IVZ balance_sheet (quarterly, 2025-12-31) — Income Tax Payable: 100100000.00
IVZ income_statement (annual, 2025-12-31) — Interest Expense: 82500000.00
IVZ income_statement (quarterly, 2025-12-31) — Interest Expense: 23000000.00
IVZ income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 82500000.00
IVZ income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 23000000.00
IVZ income_statement (annual, 2025-12-31) — Interest Income: 53900000.00
IVZ income_statement (quarterly, 2025-12-31) — Interest Income: 21600000.00
IVZ income_statement (annual, 2025-12-31) — Interest Income Non Operating: 53900000.00
IVZ income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 21600000.00
IVZ cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 77200000.00
IVZ balance_sheet (annual, 2025-12-31) — Invested Capital: 19098300000.00
IVZ balance_sheet (quarterly, 2025-12-31) — Invested Capital: 19098300000.00
IVZ cash_flow (annual, 2025-12-31) — Investing Cash Flow: -974400000.00
IVZ cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -352200000.00
IVZ balance_sheet (annual, 2025-12-31) — Investment Properties: 4100000.00
IVZ balance_sheet (quarterly, 2025-12-31) — Investment Properties: 4100000.00
IVZ balance_sheet (annual, 2025-12-31) — Investmentin Financial Assets: 1278500000.00
IVZ balance_sheet (quarterly, 2025-12-31) — Investmentin Financial Assets: 1278500000.00
IVZ balance_sheet (annual, 2025-12-31) — Investments And Advances: 2683200000.00
IVZ balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 2683200000.00
IVZ balance_sheet (annual, 2025-12-31) — Investments In Other Ventures Under Equity Method: 1375100000.00
IVZ balance_sheet (quarterly, 2025-12-31) — Investments In Other Ventures Under Equity Method: 1375100000.00
IVZ cash_flow (annual, 2025-12-31) — Issuance Of Debt: 8651300000.00
IVZ cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 2615200000.00
IVZ balance_sheet (annual, 2025-12-31) — Land And Improvements: 91900000.00
IVZ balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 91900000.00
IVZ balance_sheet (annual, 2025-12-31) — Leases: 244800000.00
IVZ balance_sheet (quarterly, 2025-12-31) — Leases: 244800000.00
IVZ balance_sheet (annual, 2025-12-31) — Loans Receivable: 7635200000.00
IVZ balance_sheet (quarterly, 2025-12-31) — Loans Receivable: 7635200000.00
IVZ balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 406700000.00
IVZ balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 406700000.00
IVZ balance_sheet (annual, 2025-12-31) — Long Term Debt: 9377800000.00
IVZ balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 9377800000.00
IVZ balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 9784500000.00
IVZ balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 9784500000.00
IVZ cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 8651300000.00
IVZ cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 2615200000.00
IVZ cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -6375900000.00
IVZ cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -1505200000.00
IVZ balance_sheet (annual, 2025-12-31) — Long Term Equity Investment: 1375100000.00
IVZ balance_sheet (quarterly, 2025-12-31) — Long Term Equity Investment: 1375100000.00
IVZ balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 922200000.00
IVZ balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 922200000.00
IVZ balance_sheet (annual, 2025-12-31) — Minority Interest: 773900000.00
IVZ balance_sheet (quarterly, 2025-12-31) — Minority Interest: 773900000.00
IVZ income_statement (annual, 2025-12-31) — Minority Interests: -106900000.00
IVZ income_statement (quarterly, 2025-12-31) — Minority Interests: -65200000.00
IVZ cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: 236500000.00
IVZ cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -123600000.00
IVZ cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -25800000.00
IVZ balance_sheet (annual, 2025-12-31) — Net Debt: 7398000000.00
IVZ balance_sheet (quarterly, 2025-12-31) — Net Debt: 7398000000.00
IVZ income_statement (annual, 2025-12-31) — Net Income: -281700000.00
IVZ income_statement (quarterly, 2025-12-31) — Net Income: -1061100000.00
IVZ income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -726300000.00
IVZ income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -1186200000.00
IVZ income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -174800000.00
IVZ income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -995900000.00
IVZ income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -281700000.00
IVZ income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -1061100000.00
IVZ income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -281700000.00
IVZ income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -1061100000.00
IVZ cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -174800000.00
IVZ cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -995900000.00
IVZ income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -174800000.00
IVZ income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -995900000.00
IVZ income_statement (annual, 2025-12-31) — Net Interest Income: -28600000.00
IVZ income_statement (quarterly, 2025-12-31) — Net Interest Income: -1400000.00
IVZ cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -1189700000.00
IVZ cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: -568500000.00
IVZ cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 2275400000.00
IVZ cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: 1110000000.00
IVZ cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 2275400000.00
IVZ cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: 1110000000.00
IVZ income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -28600000.00
IVZ income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -1400000.00
IVZ cash_flow (annual, 2025-12-31) — Net Other Financing Charges: 20600000.00
IVZ cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: 900000.00
IVZ balance_sheet (annual, 2025-12-31) — Net PPE: 378900000.00
IVZ balance_sheet (quarterly, 2025-12-31) — Net PPE: 378900000.00
IVZ cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -84300000.00
IVZ cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -23600000.00
IVZ cash_flow (annual, 2025-12-31) — Net Preferred Stock Issuance: -1740000000.00
IVZ cash_flow (quarterly, 2025-12-31) — Net Preferred Stock Issuance: -590000000.00
IVZ balance_sheet (annual, 2025-12-31) — Net Tangible Assets: -173400000.00
IVZ balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: -173400000.00
IVZ balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 901500000.00
IVZ balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 901500000.00
IVZ balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 901500000.00
IVZ balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 901500000.00
IVZ balance_sheet (annual, 2025-12-31) — Non Current Note Receivables: 7635200000.00
IVZ balance_sheet (quarterly, 2025-12-31) — Non Current Note Receivables: 7635200000.00
IVZ income_statement (annual, 2025-12-31) — Normalized EBITDA: 1535500000.00
IVZ income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 481200000.00
IVZ income_statement (annual, 2025-12-31) — Normalized Income: -281700000.00
IVZ income_statement (quarterly, 2025-12-31) — Normalized Income: -1061100000.00
IVZ cash_flow (annual, 2025-12-31) — Operating Cash Flow: 1525300000.00
IVZ cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 455800000.00
IVZ cash_flow (annual, 2025-12-31) — Operating Gains Losses: -172700000.00
IVZ cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -65600000.00
IVZ income_statement (annual, 2025-12-31) — Operating Income: -695700000.00
IVZ income_statement (quarterly, 2025-12-31) — Operating Income: -1458100000.00
IVZ income_statement (annual, 2025-12-31) — Operating Revenue: 6174900000.00
IVZ income_statement (quarterly, 2025-12-31) — Operating Revenue: 1641000000.00
IVZ balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 444000000.00
IVZ balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 444000000.00
IVZ balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -722900000.00
IVZ balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -722900000.00
IVZ income_statement (annual, 2025-12-31) — Other Gand A: 576500000.00
IVZ income_statement (quarterly, 2025-12-31) — Other Gand A: 148700000.00
IVZ income_statement (annual, 2025-12-31) — Other Income Expense: 344900000.00
IVZ income_statement (quarterly, 2025-12-31) — Other Income Expense: 114100000.00
IVZ balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 3927300000.00
IVZ balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 3927300000.00
IVZ balance_sheet (annual, 2025-12-31) — Other Investments: 29600000.00
IVZ balance_sheet (quarterly, 2025-12-31) — Other Investments: 29600000.00
IVZ cash_flow (annual, 2025-12-31) — Other Non Cash Items: 11600000.00
IVZ cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: -95300000.00
IVZ balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 857600000.00
IVZ balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 857600000.00
IVZ balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 1414900000.00
IVZ balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 1414900000.00
IVZ income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 240100000.00
IVZ income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 88700000.00
IVZ income_statement (annual, 2025-12-31) — Other Operating Expenses: 450000000.00
IVZ income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 108700000.00
IVZ balance_sheet (annual, 2025-12-31) — Other Payable: 111000000.00
IVZ balance_sheet (quarterly, 2025-12-31) — Other Payable: 111000000.00
IVZ income_statement (annual, 2025-12-31) — Otherunder Preferred Stock Dividend: 240000000.00
IVZ income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 80700000.00
IVZ balance_sheet (annual, 2025-12-31) — Payables: 231500000.00
IVZ balance_sheet (quarterly, 2025-12-31) — Payables: 231500000.00
IVZ balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 897000000.00
IVZ balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 897000000.00
IVZ balance_sheet (annual, 2025-12-31) — Preferred Stock: 2510500000.00
IVZ balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 2510500000.00
IVZ cash_flow (annual, 2025-12-31) — Preferred Stock Dividend Paid: -204600000.00
IVZ cash_flow (quarterly, 2025-12-31) — Preferred Stock Dividend Paid: -44400000.00
IVZ income_statement (annual, 2025-12-31) — Preferred Stock Dividends: 204600000.00
IVZ income_statement (quarterly, 2025-12-31) — Preferred Stock Dividends: 44400000.00
IVZ balance_sheet (annual, 2025-12-31) — Preferred Stock Equity: 2510500000.00
IVZ balance_sheet (quarterly, 2025-12-31) — Preferred Stock Equity: 2510500000.00
IVZ cash_flow (annual, 2025-12-31) — Preferred Stock Payments: -1740000000.00
IVZ cash_flow (quarterly, 2025-12-31) — Preferred Stock Payments: -590000000.00
IVZ income_statement (annual, 2025-12-31) — Pretax Income: -379400000.00
IVZ income_statement (quarterly, 2025-12-31) — Pretax Income: -1345400000.00
IVZ balance_sheet (annual, 2025-12-31) — Properties: 0.00
IVZ balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
IVZ cash_flow (annual, 2025-12-31) — Purchase Of Investment: -5397400000.00
IVZ cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -2305800000.00
IVZ cash_flow (annual, 2025-12-31) — Purchase Of PPE: -84300000.00
IVZ cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -23600000.00
IVZ balance_sheet (annual, 2025-12-31) — Receivables: 8786000000.00
IVZ balance_sheet (quarterly, 2025-12-31) — Receivables: 8786000000.00
IVZ income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 5806400000.00
IVZ income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 2832900000.00
IVZ income_statement (annual, 2025-12-31) — Reconciled Depreciation: 155900000.00
IVZ income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 36000000.00
IVZ cash_flow (annual, 2025-12-31) — Repayment Of Debt: -6375900000.00
IVZ cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -1505200000.00
IVZ cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -1863600000.00
IVZ cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -615800000.00
IVZ income_statement (annual, 2025-12-31) — Restructuring And Mergern Acquisition: 0.00
IVZ balance_sheet (annual, 2025-12-31) — Retained Earnings: 5886800000.00
IVZ balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 5886800000.00
IVZ cash_flow (annual, 2025-12-31) — Sale Of Business: 236500000.00
IVZ cash_flow (annual, 2025-12-31) — Sale Of Investment: 4207700000.00
IVZ cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 1737300000.00
IVZ income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 84000000.00
IVZ income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 23800000.00
IVZ income_statement (annual, 2025-12-31) — Selling General And Administration: 660500000.00
IVZ income_statement (quarterly, 2025-12-31) — Selling General And Administration: 172500000.00
IVZ balance_sheet (annual, 2025-12-31) — Share Issued: 566070873.00
IVZ balance_sheet (quarterly, 2025-12-31) — Share Issued: 566070873.00
IVZ income_statement (annual, 2025-12-31) — Special Income Charges: 0.00
IVZ cash_flow (annual, 2025-12-31) — Stock Based Compensation: 80000000.00
IVZ cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 20200000.00
IVZ balance_sheet (annual, 2025-12-31) — Stockholders Equity: 12231000000.00
IVZ balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 12231000000.00
IVZ balance_sheet (annual, 2025-12-31) — Tangible Book Value: -2683900000.00
IVZ balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: -2683900000.00
IVZ income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
IVZ income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
IVZ income_statement (annual, 2025-12-31) — Tax Provision: -204600000.00
IVZ income_statement (quarterly, 2025-12-31) — Tax Provision: -349500000.00
IVZ income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.21
IVZ income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.26
IVZ balance_sheet (annual, 2025-12-31) — Total Assets: 27094000000.00
IVZ balance_sheet (quarterly, 2025-12-31) — Total Assets: 27094000000.00
IVZ balance_sheet (annual, 2025-12-31) — Total Capitalization: 21608800000.00
IVZ balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 21608800000.00
IVZ balance_sheet (annual, 2025-12-31) — Total Debt: 9784500000.00
IVZ balance_sheet (quarterly, 2025-12-31) — Total Debt: 9784500000.00
IVZ balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 13004900000.00
IVZ balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 13004900000.00
IVZ income_statement (annual, 2025-12-31) — Total Expenses: 7072800000.00
IVZ income_statement (quarterly, 2025-12-31) — Total Expenses: 3150100000.00
IVZ balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 14089100000.00
IVZ balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 14089100000.00
IVZ balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 16328200000.00
IVZ balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 16328200000.00
IVZ balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 13192100000.00
IVZ balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 13192100000.00
IVZ income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -695700000.00
IVZ income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -1458100000.00
IVZ balance_sheet (annual, 2025-12-31) — Total Tax Payable: 100100000.00
IVZ balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 100100000.00
IVZ income_statement (annual, 2025-12-31) — Total Unusual Items: 0.00
IVZ income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 0.00
IVZ balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 122070873.00
IVZ balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 122070873.00
IVZ balance_sheet (annual, 2025-12-31) — Treasury Stock: 2825700000.00
IVZ balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 2825700000.00
IVZ balance_sheet (annual, 2025-12-31) — Working Capital: 9868800000.00
IVZ balance_sheet (quarterly, 2025-12-31) — Working Capital: 9868800000.00
IVZ income_statement (quarterly, 2026-03-31) — +Operating Expense: 297200000.00
IVZ income_statement (quarterly, 2026-03-31) — +Total Revenue: 1744500000.00
IVZ balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 1510800000.00
IVZ balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 1225700000.00
IVZ balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 7177600000.00
IVZ income_statement (quarterly, 2026-03-31) — Amortization: 8100000.00
IVZ income_statement (quarterly, 2026-03-31) — Amortization Of Intangibles Income Statement: 8100000.00
IVZ balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 483700000.00
IVZ income_statement (quarterly, 2026-03-31) — Basic Average Shares: 451100000.00
IVZ income_statement (quarterly, 2026-03-31) — Basic EPS: 0.51
IVZ cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 1979800000.00
IVZ cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -14200000.00
IVZ balance_sheet (quarterly, 2026-03-31) — Capital Stock: 2623700000.00
IVZ balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 1706100000.00
IVZ balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 1706100000.00
IVZ cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -133500000.00
IVZ cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 271300000.00
IVZ cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -733200000.00
IVZ cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 212600000.00
IVZ cash_flow (quarterly, 2026-03-31) — Change In Payable: -54700000.00
IVZ cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -54700000.00
IVZ cash_flow (quarterly, 2026-03-31) — Change In Receivables: -172100000.00
IVZ cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -226800000.00
IVZ cash_flow (quarterly, 2026-03-31) — Changes In Cash: -249300000.00
IVZ balance_sheet (quarterly, 2026-03-31) — Common Stock: 113200000.00
IVZ cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: -95300000.00
IVZ balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 9744500000.00
IVZ cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -69200000.00
IVZ income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 1114100000.00
IVZ balance_sheet (quarterly, 2026-03-31) — Current Assets: 10665500000.00
IVZ balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 1510800000.00
IVZ cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 33200000.00
IVZ income_statement (quarterly, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 8100000.00
IVZ cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 33200000.00
IVZ income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 8100000.00
IVZ income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 453700000.00
IVZ income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.51
IVZ income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 230400000.00
IVZ cash_flow (quarterly, 2026-03-31) — Dividend Received Cfo: 4400000.00
IVZ cash_flow (quarterly, 2026-03-31) — Dividends Received Cfi: 8300000.00
IVZ income_statement (quarterly, 2026-03-31) — EBIT: 324500000.00
IVZ income_statement (quarterly, 2026-03-31) — EBITDA: 357700000.00
IVZ income_statement (quarterly, 2026-03-31) — Earnings From Equity Interest: 34000000.00
IVZ cash_flow (quarterly, 2026-03-31) — Earnings Losses From Equity Investments: -34000000.00
IVZ cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -24400000.00
IVZ balance_sheet (quarterly, 2026-03-31) — Employee Benefits: 578800000.00
IVZ cash_flow (quarterly, 2026-03-31) — End Cash Position: 1706100000.00
IVZ cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 271300000.00
IVZ cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 198400000.00
IVZ cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: 94600000.00
IVZ balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -799000000.00
IVZ income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 147100000.00
IVZ balance_sheet (quarterly, 2026-03-31) — Goodwill: 8415900000.00
IVZ balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 12331600000.00
IVZ income_statement (quarterly, 2026-03-31) — Gross Profit: 630400000.00
IVZ balance_sheet (quarterly, 2026-03-31) — Held To Maturity Securities: 601000000.00
IVZ income_statement (quarterly, 2026-03-31) — Interest Expense: 24300000.00
IVZ income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 24300000.00
IVZ income_statement (quarterly, 2026-03-31) — Interest Income: 9200000.00
IVZ income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 9200000.00
IVZ balance_sheet (quarterly, 2026-03-31) — Invested Capital: 19184200000.00
IVZ cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -733200000.00
IVZ balance_sheet (quarterly, 2026-03-31) — Investment Properties: 4100000.00
IVZ balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 1084700000.00
IVZ balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 2496900000.00
IVZ balance_sheet (quarterly, 2026-03-31) — Investments In Other Ventures Under Equity Method: 1362900000.00
IVZ cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 3182000000.00
IVZ balance_sheet (quarterly, 2026-03-31) — Loans Receivable: 7733700000.00
IVZ balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 9439700000.00
IVZ balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 9439700000.00
IVZ cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 3182000000.00
IVZ cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -2986000000.00
IVZ balance_sheet (quarterly, 2026-03-31) — Long Term Equity Investment: 1362900000.00
IVZ balance_sheet (quarterly, 2026-03-31) — Minority Interest: 1007300000.00
IVZ income_statement (quarterly, 2026-03-31) — Minority Interests: 49500000.00
IVZ cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -69200000.00
IVZ balance_sheet (quarterly, 2026-03-31) — Net Debt: 7733600000.00
IVZ income_statement (quarterly, 2026-03-31) — Net Income: 268600000.00
IVZ income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 230400000.00
IVZ income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 219100000.00
IVZ income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 268600000.00
IVZ income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 268600000.00
IVZ cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 219100000.00
IVZ income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 219100000.00
IVZ income_statement (quarterly, 2026-03-31) — Net Interest Income: -15100000.00
IVZ cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: -727300000.00
IVZ cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: 196000000.00
IVZ cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: 196000000.00
IVZ income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -15100000.00
IVZ cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: 278000000.00
IVZ balance_sheet (quarterly, 2026-03-31) — Net PPE: 364900000.00
IVZ cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -14200000.00
IVZ balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: -76600000.00
IVZ balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 942400000.00
IVZ balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 942400000.00
IVZ income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 357700000.00
IVZ income_statement (quarterly, 2026-03-31) — Normalized Income: 268600000.00
IVZ cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 212600000.00
IVZ cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 60600000.00
IVZ income_statement (quarterly, 2026-03-31) — Operating Income: 333200000.00
IVZ income_statement (quarterly, 2026-03-31) — Operating Revenue: 1695300000.00
IVZ balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 443296629.00
IVZ balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -799000000.00
IVZ income_statement (quarterly, 2026-03-31) — Other Gand A: 147100000.00
IVZ income_statement (quarterly, 2026-03-31) — Other Income Expense: -17900000.00
IVZ balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 3915700000.00
IVZ balance_sheet (quarterly, 2026-03-31) — Other Investments: 49300000.00
IVZ cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 88100000.00
IVZ balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 971600000.00
IVZ balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 1100600000.00
IVZ income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: -51900000.00
IVZ income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 104600000.00
IVZ balance_sheet (quarterly, 2026-03-31) — Payables: 1510800000.00
IVZ balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 1510800000.00
IVZ balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 2510500000.00
IVZ cash_flow (quarterly, 2026-03-31) — Preferred Stock Dividend Paid: -38200000.00
IVZ income_statement (quarterly, 2026-03-31) — Preferred Stock Dividends: 38200000.00
IVZ balance_sheet (quarterly, 2026-03-31) — Preferred Stock Equity: 2510500000.00
IVZ income_statement (quarterly, 2026-03-31) — Pretax Income: 300200000.00
IVZ cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -1458600000.00
IVZ cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -14200000.00
IVZ balance_sheet (quarterly, 2026-03-31) — Receivables: 8959400000.00
IVZ income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 1089000000.00
IVZ income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 33200000.00
IVZ cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -2986000000.00
IVZ cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -69200000.00
IVZ balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 6021900000.00
IVZ cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 731300000.00
IVZ income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 37400000.00
IVZ income_statement (quarterly, 2026-03-31) — Selling General And Administration: 184500000.00
IVZ balance_sheet (quarterly, 2026-03-31) — Share Issued: 566096629.00
IVZ cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 34000000.00
IVZ balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 12255000000.00
IVZ balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: -2587100000.00
IVZ income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
IVZ income_statement (quarterly, 2026-03-31) — Tax Provision: 81100000.00
IVZ income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.27
IVZ balance_sheet (quarterly, 2026-03-31) — Total Assets: 26834600000.00
IVZ balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 21694700000.00
IVZ balance_sheet (quarterly, 2026-03-31) — Total Debt: 9439700000.00
IVZ balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 13262300000.00
IVZ income_statement (quarterly, 2026-03-31) — Total Expenses: 1411300000.00
IVZ balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 13572300000.00
IVZ balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 16169100000.00
IVZ balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 12061500000.00
IVZ income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: 333200000.00
IVZ balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 122800000.00
IVZ balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 2769200000.00
IVZ balance_sheet (quarterly, 2026-03-31) — Working Capital: 9154700000.00
IVZ.AX cash_flow (annual, 2021-06-30) — Classesof Cash Receiptsfrom Operating Activities: 436891.00
IVZ.AX cash_flow (annual, 2021-06-30) — Other Cash Receiptsfrom Operating Activities: 436891.00
IVZ.AX balance_sheet (annual, 2021-06-30) — Other Investments: 96143.00
IVZ.AX balance_sheet (annual, 2021-06-30) — Other Payable: 99000.00
IVZ.AX balance_sheet (annual, 2021-06-30) — Other Receivables: 17424.00
IVZ.AX income_statement (annual, 2021-06-30) — Rent And Landing Fees: 14126.00
IVZ.AX income_statement (annual, 2021-06-30) — Selling And Marketing Expense: 80365.00
IVZ.AX income_statement (annual, 2022-06-30) — +Operating Expense: 4464850.00
IVZ.AX balance_sheet (annual, 2022-06-30) — Accounts Payable: 4051782.00
IVZ.AX balance_sheet (annual, 2022-06-30) — Accounts Receivable: 245195.00
IVZ.AX income_statement (annual, 2022-06-30) — Basic Average Shares: 629692632.00
IVZ.AX income_statement (annual, 2022-06-30) — Basic EPS: -0.01
IVZ.AX cash_flow (annual, 2022-06-30) — Beginning Cash Position: 9135271.00
IVZ.AX cash_flow (annual, 2022-06-30) — Capital Expenditure: -14187462.00
IVZ.AX cash_flow (annual, 2022-06-30) — Capital Expenditure Reported: -13790676.00
IVZ.AX balance_sheet (annual, 2022-06-30) — Capital Lease Obligations: 492096.00
IVZ.AX balance_sheet (annual, 2022-06-30) — Capital Stock: 58926088.00
IVZ.AX balance_sheet (annual, 2022-06-30) — Cash And Cash Equivalents: 13718461.00
IVZ.AX balance_sheet (annual, 2022-06-30) — Cash Cash Equivalents And Short Term Investments: 13718461.00
IVZ.AX balance_sheet (annual, 2022-06-30) — Cash Equivalents: 2363874.00
IVZ.AX balance_sheet (annual, 2022-06-30) — Cash Financial: 11354587.00
IVZ.AX cash_flow (annual, 2022-06-30) — Cash Flow From Continuing Financing Activities: 20371721.00
IVZ.AX cash_flow (annual, 2022-06-30) — Cash Flow From Continuing Investing Activities: -14212090.00
IVZ.AX cash_flow (annual, 2022-06-30) — Cash Flowsfromusedin Operating Activities Direct: -1615761.00
IVZ.AX cash_flow (annual, 2022-06-30) — Changes In Cash: 4543870.00
IVZ.AX cash_flow (annual, 2022-06-30) — Classesof Cash Payments: -1617174.00
IVZ.AX balance_sheet (annual, 2022-06-30) — Common Stock: 58926088.00
IVZ.AX balance_sheet (annual, 2022-06-30) — Common Stock Equity: 37478109.00
IVZ.AX cash_flow (annual, 2022-06-30) — Common Stock Issuance: 22939423.00
IVZ.AX cash_flow (annual, 2022-06-30) — Common Stock Payments: -2567702.00
IVZ.AX balance_sheet (annual, 2022-06-30) — Current Assets: 14039506.00
IVZ.AX balance_sheet (annual, 2022-06-30) — Current Capital Lease Obligation: 127034.00
IVZ.AX balance_sheet (annual, 2022-06-30) — Current Debt And Capital Lease Obligation: 127034.00
IVZ.AX balance_sheet (annual, 2022-06-30) — Current Liabilities: 4252340.00
IVZ.AX balance_sheet (annual, 2022-06-30) — Current Provisions: 73524.00
IVZ.AX income_statement (annual, 2022-06-30) — Depreciation Amortization Depletion Income Statement: 264004.00
IVZ.AX income_statement (annual, 2022-06-30) — Depreciation And Amortization In Income Statement: 264004.00
IVZ.AX income_statement (annual, 2022-06-30) — Depreciation Income Statement: 264004.00
IVZ.AX income_statement (annual, 2022-06-30) — Diluted Average Shares: 629692632.00
IVZ.AX income_statement (annual, 2022-06-30) — Diluted EPS: -0.01
IVZ.AX income_statement (annual, 2022-06-30) — EBIT: -3732018.00
IVZ.AX income_statement (annual, 2022-06-30) — EBITDA: -3468014.00
IVZ.AX cash_flow (annual, 2022-06-30) — Effect Of Exchange Rate Changes: 39320.00
IVZ.AX cash_flow (annual, 2022-06-30) — End Cash Position: 13718461.00
IVZ.AX cash_flow (annual, 2022-06-30) — Financing Cash Flow: 20371721.00
IVZ.AX balance_sheet (annual, 2022-06-30) — Foreign Currency Translation Adjustments: 379439.00
IVZ.AX cash_flow (annual, 2022-06-30) — Free Cash Flow: -15803223.00
IVZ.AX balance_sheet (annual, 2022-06-30) — Gains Losses Not Affecting Retained Earnings: 3144107.00
IVZ.AX income_statement (annual, 2022-06-30) — General And Administrative Expense: 2612020.00
IVZ.AX balance_sheet (annual, 2022-06-30) — Gross PPE: 28971028.00
IVZ.AX income_statement (annual, 2022-06-30) — Interest Expense: 54163.00
IVZ.AX income_statement (annual, 2022-06-30) — Interest Expense Non Operating: 54163.00
IVZ.AX income_statement (annual, 2022-06-30) — Interest Income: 1413.00
IVZ.AX income_statement (annual, 2022-06-30) — Interest Income Non Operating: 1413.00
IVZ.AX cash_flow (annual, 2022-06-30) — Interest Received Direct: 1413.00
IVZ.AX balance_sheet (annual, 2022-06-30) — Invested Capital: 37478109.00
IVZ.AX cash_flow (annual, 2022-06-30) — Investing Cash Flow: -14212090.00
IVZ.AX balance_sheet (annual, 2022-06-30) — Investments And Advances: 120771.00
IVZ.AX cash_flow (annual, 2022-06-30) — Issuance Of Capital Stock: 22939423.00
IVZ.AX balance_sheet (annual, 2022-06-30) — Long Term Capital Lease Obligation: 365062.00
IVZ.AX balance_sheet (annual, 2022-06-30) — Long Term Debt And Capital Lease Obligation: 365062.00
IVZ.AX balance_sheet (annual, 2022-06-30) — Machinery Furniture Equipment: 284344.00
IVZ.AX balance_sheet (annual, 2022-06-30) — Minority Interest: 1035794.00
IVZ.AX income_statement (annual, 2022-06-30) — Minority Interests: 142316.00
IVZ.AX cash_flow (annual, 2022-06-30) — Net Common Stock Issuance: 20371721.00
IVZ.AX income_statement (annual, 2022-06-30) — Net Income: -3643865.00
IVZ.AX income_statement (annual, 2022-06-30) — Net Income Common Stockholders: -3643865.00
IVZ.AX income_statement (annual, 2022-06-30) — Net Income Continuous Operations: -3786181.00
IVZ.AX income_statement (annual, 2022-06-30) — Net Income From Continuing And Discontinued Operation: -3643865.00
IVZ.AX income_statement (annual, 2022-06-30) — Net Income From Continuing Operation Net Minority Interest: -3643865.00
IVZ.AX income_statement (annual, 2022-06-30) — Net Income Including Noncontrolling Interests: -3786181.00
IVZ.AX income_statement (annual, 2022-06-30) — Net Interest Income: -52750.00
IVZ.AX income_statement (annual, 2022-06-30) — Net Non Operating Interest Income Expense: -52750.00
IVZ.AX cash_flow (annual, 2022-06-30) — Net Other Financing Charges: 3589926.00
IVZ.AX cash_flow (annual, 2022-06-30) — Net Other Investing Changes: -24628.00
IVZ.AX balance_sheet (annual, 2022-06-30) — Net PPE: 28971028.00
IVZ.AX cash_flow (annual, 2022-06-30) — Net PPE Purchase And Sale: -396786.00
IVZ.AX balance_sheet (annual, 2022-06-30) — Net Tangible Assets: 37478109.00
IVZ.AX income_statement (annual, 2022-06-30) — Normalized EBITDA: -3468014.00
IVZ.AX income_statement (annual, 2022-06-30) — Normalized Income: -3643865.00
IVZ.AX income_statement (annual, 2022-06-30) — Operating Income: -4464850.00
IVZ.AX balance_sheet (annual, 2022-06-30) — Ordinary Shares Number: 746732948.00
IVZ.AX balance_sheet (annual, 2022-06-30) — Other Current Assets: 75850.00
IVZ.AX balance_sheet (annual, 2022-06-30) — Other Equity Adjustments: 2764668.00
IVZ.AX income_statement (annual, 2022-06-30) — Other Gand A: 162917.00
IVZ.AX income_statement (annual, 2022-06-30) — Other Income Expense: 731419.00
IVZ.AX balance_sheet (annual, 2022-06-30) — Other Investments: 120771.00
IVZ.AX income_statement (annual, 2022-06-30) — Other Non Operating Income Expenses: 731419.00
IVZ.AX income_statement (annual, 2022-06-30) — Other Operating Expenses: 1465188.00
IVZ.AX balance_sheet (annual, 2022-06-30) — Other Properties: 28686684.00
IVZ.AX balance_sheet (annual, 2022-06-30) — Payables: 4051782.00
IVZ.AX balance_sheet (annual, 2022-06-30) — Payables And Accrued Expenses: 4051782.00
IVZ.AX cash_flow (annual, 2022-06-30) — Paymentsto Suppliersfor Goodsand Services: -1617174.00
IVZ.AX income_statement (annual, 2022-06-30) — Pretax Income: -3786181.00
IVZ.AX cash_flow (annual, 2022-06-30) — Purchase Of PPE: -396786.00
IVZ.AX balance_sheet (annual, 2022-06-30) — Receivables: 245195.00
IVZ.AX income_statement (annual, 2022-06-30) — Reconciled Depreciation: 264004.00
IVZ.AX income_statement (annual, 2022-06-30) — Rent And Landing Fees: 27655.00
IVZ.AX cash_flow (annual, 2022-06-30) — Repurchase Of Capital Stock: -2567702.00
IVZ.AX balance_sheet (annual, 2022-06-30) — Retained Earnings: -24592086.00
IVZ.AX income_statement (annual, 2022-06-30) — Salaries And Wages: 2421448.00
IVZ.AX income_statement (annual, 2022-06-30) — Selling And Marketing Expense: 123638.00
IVZ.AX income_statement (annual, 2022-06-30) — Selling General And Administration: 2735658.00
IVZ.AX balance_sheet (annual, 2022-06-30) — Share Issued: 746732948.00
IVZ.AX balance_sheet (annual, 2022-06-30) — Stockholders Equity: 37478109.00
IVZ.AX balance_sheet (annual, 2022-06-30) — Tangible Book Value: 37478109.00
IVZ.AX income_statement (annual, 2022-06-30) — Tax Effect Of Unusual Items: 0.00
IVZ.AX income_statement (annual, 2022-06-30) — Tax Provision: 0.00
IVZ.AX income_statement (annual, 2022-06-30) — Tax Rate For Calcs: 0.00
IVZ.AX balance_sheet (annual, 2022-06-30) — Total Assets: 43131305.00
IVZ.AX balance_sheet (annual, 2022-06-30) — Total Capitalization: 37478109.00
IVZ.AX balance_sheet (annual, 2022-06-30) — Total Debt: 492096.00
IVZ.AX balance_sheet (annual, 2022-06-30) — Total Equity Gross Minority Interest: 38513903.00
IVZ.AX balance_sheet (annual, 2022-06-30) — Total Liabilities Net Minority Interest: 4617402.00
IVZ.AX balance_sheet (annual, 2022-06-30) — Total Non Current Assets: 29091799.00
IVZ.AX balance_sheet (annual, 2022-06-30) — Total Non Current Liabilities Net Minority Interest: 365062.00
IVZ.AX balance_sheet (annual, 2022-06-30) — Working Capital: 9787166.00
IVZ.AX income_statement (annual, 2023-06-30) — +Operating Expense: 5069715.00
IVZ.AX balance_sheet (annual, 2023-06-30) — Accounts Payable: 1379801.00
IVZ.AX balance_sheet (annual, 2023-06-30) — Accounts Receivable: 344486.00
IVZ.AX income_statement (annual, 2023-06-30) — Basic Average Shares: 886755485.00
IVZ.AX income_statement (annual, 2023-06-30) — Basic EPS: -0.01
IVZ.AX cash_flow (annual, 2023-06-30) — Beginning Cash Position: 13718461.00
IVZ.AX cash_flow (annual, 2023-06-30) — Capital Expenditure: -48666035.00
IVZ.AX cash_flow (annual, 2023-06-30) — Capital Expenditure Reported: -48666035.00
IVZ.AX balance_sheet (annual, 2023-06-30) — Capital Lease Obligations: 365063.00
IVZ.AX balance_sheet (annual, 2023-06-30) — Capital Stock: 117371778.00
IVZ.AX balance_sheet (annual, 2023-06-30) — Cash And Cash Equivalents: 22931927.00
IVZ.AX balance_sheet (annual, 2023-06-30) — Cash Cash Equivalents And Short Term Investments: 22931927.00
IVZ.AX balance_sheet (annual, 2023-06-30) — Cash Financial: 22931927.00
IVZ.AX cash_flow (annual, 2023-06-30) — Cash Flow From Continuing Financing Activities: 60922716.00
IVZ.AX cash_flow (annual, 2023-06-30) — Cash Flow From Continuing Investing Activities: -49456168.00
IVZ.AX cash_flow (annual, 2023-06-30) — Cash Flowsfromusedin Operating Activities Direct: -2570432.00
IVZ.AX cash_flow (annual, 2023-06-30) — Changes In Cash: 8896116.00
IVZ.AX cash_flow (annual, 2023-06-30) — Classesof Cash Payments: -2672326.00
IVZ.AX balance_sheet (annual, 2023-06-30) — Common Stock: 117371778.00
IVZ.AX balance_sheet (annual, 2023-06-30) — Common Stock Equity: 95317017.00
IVZ.AX cash_flow (annual, 2023-06-30) — Common Stock Issuance: 64293811.00
IVZ.AX cash_flow (annual, 2023-06-30) — Common Stock Payments: -3371095.00
IVZ.AX balance_sheet (annual, 2023-06-30) — Current Assets: 23359160.00
IVZ.AX balance_sheet (annual, 2023-06-30) — Current Capital Lease Obligation: 145906.00
IVZ.AX balance_sheet (annual, 2023-06-30) — Current Debt And Capital Lease Obligation: 145906.00
IVZ.AX balance_sheet (annual, 2023-06-30) — Current Liabilities: 2684426.00
IVZ.AX balance_sheet (annual, 2023-06-30) — Current Provisions: 92774.00
IVZ.AX income_statement (annual, 2023-06-30) — Depreciation Amortization Depletion Income Statement: 250383.00
IVZ.AX income_statement (annual, 2023-06-30) — Depreciation And Amortization In Income Statement: 250383.00
IVZ.AX income_statement (annual, 2023-06-30) — Depreciation Income Statement: 250383.00
IVZ.AX income_statement (annual, 2023-06-30) — Diluted Average Shares: 886755485.00
IVZ.AX income_statement (annual, 2023-06-30) — Diluted EPS: -0.01
IVZ.AX income_statement (annual, 2023-06-30) — EBIT: -4887287.00
IVZ.AX income_statement (annual, 2023-06-30) — EBITDA: -4636904.00
IVZ.AX cash_flow (annual, 2023-06-30) — Effect Of Exchange Rate Changes: 317350.00
IVZ.AX cash_flow (annual, 2023-06-30) — End Cash Position: 22931927.00
IVZ.AX cash_flow (annual, 2023-06-30) — Financing Cash Flow: 60922716.00
IVZ.AX balance_sheet (annual, 2023-06-30) — Foreign Currency Translation Adjustments: 337074.00
IVZ.AX cash_flow (annual, 2023-06-30) — Free Cash Flow: -51236467.00
IVZ.AX balance_sheet (annual, 2023-06-30) — Gains Losses Not Affecting Retained Earnings: 7175304.00
IVZ.AX income_statement (annual, 2023-06-30) — General And Administrative Expense: 2720186.00
IVZ.AX balance_sheet (annual, 2023-06-30) — Gross PPE: 75473488.00
IVZ.AX income_statement (annual, 2023-06-30) — Interest Expense: 64641.00
IVZ.AX income_statement (annual, 2023-06-30) — Interest Expense Non Operating: 64641.00
IVZ.AX income_statement (annual, 2023-06-30) — Interest Income: 101894.00
IVZ.AX income_statement (annual, 2023-06-30) — Interest Income Non Operating: 101894.00
IVZ.AX cash_flow (annual, 2023-06-30) — Interest Received Direct: 101894.00
IVZ.AX balance_sheet (annual, 2023-06-30) — Invested Capital: 95317017.00
IVZ.AX cash_flow (annual, 2023-06-30) — Investing Cash Flow: -49456168.00
IVZ.AX balance_sheet (annual, 2023-06-30) — Investments And Advances: 120771.00
IVZ.AX cash_flow (annual, 2023-06-30) — Issuance Of Capital Stock: 64293811.00
IVZ.AX balance_sheet (annual, 2023-06-30) — Leases: 732588.00
IVZ.AX balance_sheet (annual, 2023-06-30) — Long Term Capital Lease Obligation: 219157.00
IVZ.AX balance_sheet (annual, 2023-06-30) — Long Term Debt And Capital Lease Obligation: 219157.00
IVZ.AX balance_sheet (annual, 2023-06-30) — Machinery Furniture Equipment: 174828.00
IVZ.AX balance_sheet (annual, 2023-06-30) — Minority Interest: 732819.00
IVZ.AX income_statement (annual, 2023-06-30) — Minority Interests: 292460.00
IVZ.AX cash_flow (annual, 2023-06-30) — Net Common Stock Issuance: 60922716.00
IVZ.AX income_statement (annual, 2023-06-30) — Net Income: -4659468.00
IVZ.AX income_statement (annual, 2023-06-30) — Net Income Common Stockholders: -4659468.00
IVZ.AX income_statement (annual, 2023-06-30) — Net Income Continuous Operations: -4951928.00
IVZ.AX income_statement (annual, 2023-06-30) — Net Income From Continuing And Discontinued Operation: -4659468.00
IVZ.AX income_statement (annual, 2023-06-30) — Net Income From Continuing Operation Net Minority Interest: -4659468.00
IVZ.AX income_statement (annual, 2023-06-30) — Net Income Including Noncontrolling Interests: -4951928.00
IVZ.AX income_statement (annual, 2023-06-30) — Net Interest Income: 37253.00
IVZ.AX income_statement (annual, 2023-06-30) — Net Non Operating Interest Income Expense: 37253.00
IVZ.AX cash_flow (annual, 2023-06-30) — Net Other Financing Charges: 3842183.00